Sanolla Overview
Sanolla provides physicians and patients with smart diagnostic solutions designed to support the early assessment and monitoring of cardiopulmonary conditions such as congestive heart failure, pneumonia, asthma, chronic obstructive pulmonary disease, COVID-19, and more. Based on AI-powered detection and analysis of previously inaccessible body infrasounds and other important vital signs (e.g., ECG, heart rate, oxygen level, body temperature, and respiratory cycle), Sanolla's products can provide immediate and accurate assessment, reducing unnecessary in-clinic visits, saving time and money, and lowering the associated risk of exposure to infections.
Cumulative Funding Raised Over Time ($)
$5.0MApr 2016
$11.0MApr 2022
Latest News
growth-positive
/PRNewswire/ -- Sanolla, a leader in advanced auscultation and AI-powered diagnostic tools, is advancing clinical practice with the launch of its VoqX smart...
Sanolla has launched its VoqX smart stethoscope, the first AI-powered device capable of analyzing both heart and lung sounds, now directly available to physicians. The VoqX offers full-spectrum auscultation, including low-frequency infrasound, and provides real-time AI analysis to transform how healthcare professionals detect and manage cardiopulmonary conditions. The device is FDA-certified and offers advanced diagnostic capabilities, making it a significant advancement in auscultation technology. Sanolla aims to make this powerful tool accessible to frontline clinicians, offering it at an introductory price of $499. The VoqX is designed for use in various healthcare settings and is protected by international patents.
Product StageCustomers
growth-positive
Israeli Health Tech Startups Nab Innovation Awards In Taiwan
Israeli health tech startups Sanolla and Naor (Rapid Diagnostics) were awarded the Breakthrough Innovation Award at the InoVEX 2022 Pitch Contest in Taiwan. They also received the Startup Terrace Award, which includes a $40,000 grant and office space. Sanolla develops medical diagnosis and patient monitoring solutions, while Rapid Diagnostics has an innovative engine for rapid molecular and on-site diagnosis. The companies participated in the IP²LaunchPad program for Israeli companies entering the far east markets and Taiwanese innovation ecosystem. The program aims to accelerate the innovation ecosystem in Taiwan. Due to entry restrictions, the companies participated remotely.
PartnersInvestment
growth-positive
Listening in: Top Innovations in Stethoscopes - MedicalExpo e-Magazine
The article discusses the advancements and innovations in the field of stethoscopes and their impact on healthcare. It highlights the development of digital stethoscopes by companies like Thinklabs Medical, Sanolla, and Eko, which offer features like amplification, real-time display of sound waveform, and AI algorithms for detecting various conditions. Polish company StethoMe has developed a home device for monitoring childhood asthma and other respiratory conditions. The article emphasizes the shift from traditional stethoscopes to more innovative solutions and the potential benefits of these advancements in improving healthcare diagnosis and treatment.
Customers
growth-positive
החברות הישראליות ממשיכות לקטוף פרסים בטייוואן; שתי החברות ישראליות הגיעו לגמר בתחרות של כנס החדשנות של אסיה וזכו בהכרה על חדשנות פורצת דרך ובפרסים כספיים New-Tech OnLine
Israeli companies Sanolla and Raphid Diagnostics won the Startup Terrace Award at the InnoVEX 2022 Pitch Contest, held as part of the InnoVEX conference in Taiwan. The companies showcased their innovative medical technologies and were recognized for their entry into the Far East markets. The IP²LaunchPad program, which aims to accelerate the entry of Israeli companies into the Taiwanese market, facilitated their participation. The program is supported by the Small and Medium Enterprise Administration of Taiwans Ministry of Economic Affairs and managed by Taiwanese company i2i. The Israeli companies participated remotely due to travel restrictions, while program managers represented them physically at the conference.
Partners
growth-positive
Sanolla Gets FDA Clearance For World's First AI-Powered Infrasound Stethoscope
Israeli medtech startup Sanolla has received FDA 510(k) clearance for its AI-powered diagnostic device VoqX, the first stethoscope that can listen to infrasound. The clearance allows Sanolla to make VoqX available for clinical use in the US and Israel. The company aims to develop a stethoscope for remote care monitoring. Sanollas technology picks up low-frequency sound waves between 3 and 40 Hz, providing diagnostic information beyond what is available in the audible spectrum. The VoqX stethoscope has been extensively used for studies at the Mayo Clinic and Israeli hospitals. Sanolla has raised $16 million in funding and plans to begin a Round A funding raise to cover various aspects of the business.
CustomersInvestment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $16M |
| Last funding | $6M |
| Stage | Seed |
| Rounds | 6 |
| Investors | 4 |
Team Members
4
Employees: 11-50
Web & Social Links
| Website | sanolla.com |
Locations
HaMesila St 19, Nesher, Israel
Photos & Videos
3 item(s)
Sanolla Business
Business models
B2B2C, B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical DiagnosticsPatient Remote MonitoringTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersCore Technology
Platforms & InterfacesSoftwareArtificial IntelligenceDeep LearningMachine LearningSensingTags (14)
telehealthmedical-devicesmachine-learningmedical-technologiesartificial-intelligencedata-analyticsdeep-learningmonitoringdiagnosticspulmonarynon-invasivesensorsdigital-healthcareearly-detectionGeographic Markets
Western EuropeSoutheast AsiaNorth AmericaNorthern EuropeEuropeOceaniaSanolla Financials
$16M
Total funding
Undisclosed
Capital raised
$6M
Last funding
Seed
Funding stage
6
Total rounds
4
Investors
Cumulative Funding Raised Over Time ($)
$5.0MApr 2016
$11.0MApr 2022
Private Equity Funding
Seed
Apr 2022
$6M
Together We Invest, KYTO
Seed
Apr 2016
$5M
NextLeap Ventures, Undisclosed Investor(s)
Non-Equity Funding
GrantEvent
Sep 2020
$3.1M
EU Horizon 2020
GrantEvent
Jan 2020
$700K
Israel Innovation Authority
GrantEvent
Jan 2018
$700K
Israel Innovation Authority
GrantEvent
Jan 2017
$500K
Israel Innovation Authority
Sanolla Lifecycle
Cumulative Funding Raised Over Time
$5.0MApr 2016
$11.0MApr 2022
All Events
Seed
Apr 2022
$6M
Together We Invest, KYTO
Seed
Apr 2016
$5M
NextLeap Ventures, Undisclosed Investor(s)
GrantEvent
Sep 2020
$3.1M
EU Horizon 2020
GrantEvent
Jan 2020
$700K
Israel Innovation Authority
GrantEvent
Jan 2018
$700K
Israel Innovation Authority
GrantEvent
Jan 2017
$500K
Israel Innovation Authority
Sanolla News
16 articles
growth-positive
/PRNewswire/ -- Sanolla, a leader in advanced auscultation and AI-powered diagnostic tools, is advancing clinical practice with the launch of its VoqX smart...
Sanolla has launched its VoqX smart stethoscope, the first AI-powered device capable of analyzing both heart and lung sounds, now directly available to physicians. The VoqX offers full-spectrum auscultation, including low-frequency infrasound, and provides real-time AI analysis to transform how healthcare professionals detect and manage cardiopulmonary conditions. The device is FDA-certified and offers advanced diagnostic capabilities, making it a significant advancement in auscultation technology. Sanolla aims to make this powerful tool accessible to frontline clinicians, offering it at an introductory price of $499. The VoqX is designed for use in various healthcare settings and is protected by international patents.
Product StageCustomers
growth-positive
Israeli Health Tech Startups Nab Innovation Awards In Taiwan
Israeli health tech startups Sanolla and Naor (Rapid Diagnostics) were awarded the Breakthrough Innovation Award at the InoVEX 2022 Pitch Contest in Taiwan. They also received the Startup Terrace Award, which includes a $40,000 grant and office space. Sanolla develops medical diagnosis and patient monitoring solutions, while Rapid Diagnostics has an innovative engine for rapid molecular and on-site diagnosis. The companies participated in the IP²LaunchPad program for Israeli companies entering the far east markets and Taiwanese innovation ecosystem. The program aims to accelerate the innovation ecosystem in Taiwan. Due to entry restrictions, the companies participated remotely.
PartnersInvestment
growth-positive
Listening in: Top Innovations in Stethoscopes - MedicalExpo e-Magazine
The article discusses the advancements and innovations in the field of stethoscopes and their impact on healthcare. It highlights the development of digital stethoscopes by companies like Thinklabs Medical, Sanolla, and Eko, which offer features like amplification, real-time display of sound waveform, and AI algorithms for detecting various conditions. Polish company StethoMe has developed a home device for monitoring childhood asthma and other respiratory conditions. The article emphasizes the shift from traditional stethoscopes to more innovative solutions and the potential benefits of these advancements in improving healthcare diagnosis and treatment.
Customers
growth-positive
החברות הישראליות ממשיכות לקטוף פרסים בטייוואן; שתי החברות ישראליות הגיעו לגמר בתחרות של כנס החדשנות של אסיה וזכו בהכרה על חדשנות פורצת דרך ובפרסים כספיים New-Tech OnLine
Israeli companies Sanolla and Raphid Diagnostics won the Startup Terrace Award at the InnoVEX 2022 Pitch Contest, held as part of the InnoVEX conference in Taiwan. The companies showcased their innovative medical technologies and were recognized for their entry into the Far East markets. The IP²LaunchPad program, which aims to accelerate the entry of Israeli companies into the Taiwanese market, facilitated their participation. The program is supported by the Small and Medium Enterprise Administration of Taiwans Ministry of Economic Affairs and managed by Taiwanese company i2i. The Israeli companies participated remotely due to travel restrictions, while program managers represented them physically at the conference.
Partners
growth-positive
Sanolla Gets FDA Clearance For World's First AI-Powered Infrasound Stethoscope
Israeli medtech startup Sanolla has received FDA 510(k) clearance for its AI-powered diagnostic device VoqX, the first stethoscope that can listen to infrasound. The clearance allows Sanolla to make VoqX available for clinical use in the US and Israel. The company aims to develop a stethoscope for remote care monitoring. Sanollas technology picks up low-frequency sound waves between 3 and 40 Hz, providing diagnostic information beyond what is available in the audible spectrum. The VoqX stethoscope has been extensively used for studies at the Mayo Clinic and Israeli hospitals. Sanolla has raised $16 million in funding and plans to begin a Round A funding raise to cover various aspects of the business.
CustomersInvestment
פריצת דרך כחול לבן: סטטוסקופ בעל אבחון מתקדם רשת 13
growth-positive
Artificial intelligence in the service of the family doctor
Sanolla, a medical technology company, is developing a new type of stethoscope called VoqX. The stethoscope uses artificial intelligence technology to detect body sounds that the human ear cannot hear, providing quick and accurate diagnoses. The device can identify various medical conditions, including heart and lung diseases, and even COVID-19. Sanolla plans to release VoqX to the market by the end of 2021 and has already received interest from medical organizations and companies. They also plan to launch a home version of the product called PyXy, which will allow patients to conduct self-examinations and communicate with healthcare professionals. Sanolla aims to revolutionize medical diagnostics and improve patient outcomes.
Customers
Not applicable
biomed
The text provided does not contain any information about a company, its operations, or any business-related events. It appears to be the HTML code for a webpage titled biomed, which includes various scripts and stylesheets for the webpages functionality and appearance. No specific details about a company, its activities, or any business-related events are mentioned in the text.
Not applicable
growth-positive
Sounds of Life: Unlocking Body Sounds using Sanolla's AI Technology
Sanolla, a medical device company, aims to revolutionize primary care diagnosis using infrasound technology. The company was founded by Dr. Doron Adler, who has a background in the medical device industry. Sanollas mission is to develop AI-based product lines for professional medical staff, home users, hospitals, clinics, and POCs. The COVID-19 pandemic has had a significant impact on Sanolla, leading them to shift their R&D efforts towards fighting COVID-19. They have collected clinical data of COVID-19 patients and received funding for their AI-based device made for remote and home use. Sanolla is the only company using infrasound technology, which sets them apart from their competitors. They aim to provide a comprehensive solution for professionals and home users, without the need for a smartphone or internet connection. Sanolla is actively seeking joint ventures to maximize their potential.
CustomersPartners
growth-positive
Plug and Play Japan has selected 103 startups for its Winter/Spring 2021 Batch Accelerator Program
Plug and Play Japan has selected 103 startups for their Winter/Spring 2021 Batch accelerator program, including a newly launched vertical, Smart Cities. The program will be carried out from December 2020 to March 2021, with 42 large domestic corporate partner companies involved. The selected startups will have access to mentoring, networking, and lectures to accelerate their businesses. The Winter/Spring 2021 Summit (Demo Day) will be held in Tokyo, Kyoto, and Osaka in March 2021. Plug and Play is a global innovation platform that provides accelerator programs and corporate innovation services. Since its inception in 2006, Plug and Play has expanded worldwide and created a startup ecosystem in various industries.
PartnersExpand
https://copd.doctorsonly.co.il/2020/10/209477/
growth-positive
N12 - הפטנט הישראלי שיאבחן קורונה בתוך פחות מדקה
Israeli company Sonola has developed a new stethoscope that can diagnose COVID-19 and other lung diseases in less than a minute. The device, which does not require headphones, automatically detects the attachment to the body and displays the results on a screen. Sonola plans to conduct pilot testing at Ichilov Hospital and later in private facilities. The company estimates that the pilot phase will last about a month, and once the device is ready for market, it will be priced at $1,000 for consumers in Israel. Deputy Health Minister Yoav Kisch praised the Israeli innovation and expressed hope that it could be a breakthrough in rapid, affordable, and simple testing.
Customers
growth-positive
Listen to body sounds, diagnose diseases
Sanolla, a medical technology company, is collaborating with the Chief Scientist’s office at the Ministry of Science and Technology to develop efficient and accurate corona testing using their technology that listens to body noises and sensations. The technology is currently undergoing clinical trials in Israel. Sanollas product, VoqX™, is an AI-based infrasound stethoscope that can detect a wide range of medical conditions by analyzing body sounds. The company is also working on a home version of the product called PyXy™, which will allow individuals to perform various tests at home. The product is expected to receive EU approval before 2021. Sanollas technology has garnered interest from strategic partners and manufacturers.
CustomersPartners
https://finance.yahoo.com/news/sanolla-wins-horizon-2020-funding-120000268.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cubGlua2VkaW4uY29tLw&guce_referrer_sig=AQAAAIZkRu4GZXzmvBIM3inOd7hfXxiFGQF7tC71Urik46p2PrCEjmCvSGhCOwXTwdQ-S7YTk8_PjCSIjzXNrvhMWatc35YwQaeLijiEZFXCX7tHB_JHD7nyZDlZF-NUyzn_QJFjqTC9Zye7zfkt2wkZ2JxytLVQcBrqt9nuscibseGA
growth-positive
Nine Israeli organizations granted EU funding under Horizon 2020 program
Nine Israeli organizations have been granted EU funding under the Horizon 2020 program to combat Covid-19. The organizations, including research institutions, NGOs, governmental bodies, and companies, received a total of NIS 18 million ($5.3 million). They will participate in eight collaborative projects aimed at developing medical technologies and databases to address the social and economic effects of the pandemic. The partnerships involve companies like Sanolla, SKM Aeronautics, PhotosonicSys, the University of Haifa, the Hebrew University, MDM Projects, Siemens Israel, and Magen David Adom. The projects will focus on areas such as AI diagnostics, production of silicon masks, quick testing devices, monitoring platforms, and air purification. The funding will support long-term R&D and the testing of proposed solutions.
PartnersCustomers
growth-positive
Israel's Bat-Call makes a good call with auscultation for COVID-19 approach
Bat-Call Ltd. is using its auscultation technology to support the early detection and monitoring of COVID-19 patients. The companys patented AI infra-sound analysis and deep learning classification technologies are being utilized in the battle against the pandemic.
CustomersPartners
Sanolla Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 21 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 15 classification IDs that could be used for matching.
Sanolla Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 99/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 515448702 |
| Crunchbase | bat-call-medical-device |
| Phone | +97248321663 |
| Creator | Moshe Barel |
| Creator email | moshe@nova-sight.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-09-15T00:00:00.000Z |
| Created | 2020-05-19T00:00:00.000Z |
| Claimed | Yes |